How to Find a Licensed Medical Device Distributor in Vietnam

Vietnam's medical device market has undergone dramatic regulatory reform since 2022 — Circular 05/2022/TT-BYT modernised the registration framework, while chronic DAV processing backlogs created a parallel Import Permit system that allowed unregistered devices to enter on temporary permits. For foreign manufacturers, finding a Vietnamese importer with the regulatory expertise to navigate both the registration backlog and the new compliance environment is critical to long-term market access.

Key Takeaways

• Vietnam's Drug Administration of Vietnam (DAV) under the Ministry of Health regulates medical devices. All devices must be registered via DAV before commercial import — or imported on a temporary Import Permit (Giấy phép nhập khẩu) while registration is pending.
• The registration (Giấy lưu hành) is held by the Vietnamese importer — not the foreign manufacturer. If you change importer, you must re-register or transfer the certificate, a process that typically takes 6–12 months.
• Vietnam experienced major DAV processing backlogs from 2022–2024 driven by regulatory reform transitioning from Decree 36/2016 to Circular 05/2022 and then to the Medical Device Law 2023. Many importers used Import Permits to bridge supply — verify which of your target importer's products are fully registered vs import-permit-only.
• Vietnam's Type A–D classification (AMDD-aligned) means devices classified in other ASEAN markets map relatively predictably — but Vietnam-specific labelling requirements in Vietnamese language are mandatory and often underestimated.

Vietnam's Evolving Regulatory Landscape

The Drug Administration of Vietnam (DAV), operating under the Ministry of Health (MOH), serves as the competent authority for medical devices in Vietnam. The regulatory framework has undergone significant transformation in recent years — Circular 05/2022/TT-BYT replaced the older Decree 36/2016/ND-CP framework and introduced revised classification procedures, new importer obligations, and an updated technical file format. Subsequently, the Medical Device Law 2023(Law No. 01/2024/QH15) marked Vietnam's first standalone medical device law, signalling continued regulatory evolution through 2024–2026.

Vietnam employs an AMDD-aligned Type A–D classificationsystem: Type A (lowest risk) through Type D (highest risk). This broadly mirrors the ASEAN classification principles, enabling foreign manufacturers with existing ASEAN registrations to predict their Vietnamese classification with reasonable confidence — though Vietnam-specific nuances and labelling obligations apply in all cases.

Step 1 — Verify Importer's Regulatory Status

Before evaluating any Vietnamese importer commercially, conduct a mandatory regulatory status check. A company's authorisation as a medical device importer (Cơ sở nhập khẩu) is a fundamental prerequisite — and with Vietnam's ongoing regulatory reform, not all importers have maintained full compliance with Circular 05/2022/TT-BYT requirements.

Check DAV's Online Database

Access the official DAV portal (dav.gov.vn) or the national public services portal (dichvucong.gov.vn) to verify the importer's business registration and their Device Establishment (Cơ sở nhập khẩu) authorisation. Confirm the establishment licence is current and covers your device category.

Review the Registration vs Import-Permit Ratio

Ask to see the importer's current product portfolio and distinguish between fully registered products (holding a Giấy lưu hànhregistration certificate) and those operating on Import Permits (provisional status). A high permit-to-registration ratio signals a distributor still catching up from the 2022–2024 regulatory backlog — this creates long-term compliance risk for your products.

Verify Circular 05/2022 Compliance

Confirm the importer meets key Circular 05/2022/TT-BYT requirements: a designated Qualified Person (QP) for device compliance, a functioning complaint handling system, and adverse event reporting capability to DAV. Some smaller importers have not yet fully implemented these post-market requirements.

Step 2 — Understand Vietnam's Type A–D Classification

Vietnam's classification system under Circular 05/2022 determines the registration pathway, required documentation, DAV review depth, and realistic timeline for your product. Correctly classifying your device is critical to setting accurate expectations for your importer partnership.

Step 3 — Evaluate Regulatory Capability

Finding an importer with strong commercial networks is necessary, but not sufficient. In Vietnam's current environment, what distinguishes a high-quality importer is their demonstrated ability to successfully navigate DAV's registration process — including the complex transition from Decree 36/2016 to Circular 05/2022 that many importers are still completing.

Request the Registration Portfolio

Ask how many fully registered products (with active Giấy lưu hành) the importer currently holds. Request registration certificates for 3–4 products in your device class so you can verify them directly against the DAV database — this takes approximately 15 minutes and is the single most reliable indicator of regulatory competence.

Ask About the 2022 Regulatory Transition

Importers who successfully transitioned their portfolios from Decree 36/2016 to Circular 05/2022 have demonstrated resilience, regulatory competence, and an ability to manage uncertainty. Ask directly: “How did you manage the transition to Circular 05/2022 and which products did you transition first?” The answer reveals their process maturity.

Confirm QP Designation and PMS Systems

Verify that the importer has a Qualified Person (QP) formally designated for medical device complaint handling and adverse event reporting — a Circular 05/2022 requirement. Ask to see evidence of the QP appointment and whether they have submitted any Field Safety Corrective Actions (FSCAs) to DAV. Some smaller importers have not yet implemented these systems.

Step 4 — Assess Hospital and Procurement Access

Vietnam's medical device market is split between government hospital procurement (dominated by MOH-level tenders and provincial hospital tenders) and a growing private sector led by groups such as Vinmec, FV Hospital, Thu Cuc, and Hoan My. Geographic coverage is critical — the market is effectively bifurcated between the northern hub (Hanoi) and the southern hub (Ho Chi Minh City), and a distributor with strong presence in only one region will leave significant market access unrealised.

Step 5 — Conduct Due Diligence

Before signing a distribution and registration agreement with a Vietnamese importer, conduct structured due diligence using the checklist below as a minimum standard. Given that the Giấy lưu hành registration certificate will be held in the importer's name, this due diligence protects your long-term market access.

• Verify importer's business registration (Enterprise Registration Certificate) and confirm authorisation as a medical device importer (Cơ sở nhập khẩu)
• Request list of fully registered products with Giấy lưu hành certificate numbers — verify at least 3 against the DAV database directly
• Separately identify how many products are on Import Permits (provisional status) vs full registration, and ask about conversion timeline plans
• Request Circular 05/2022 compliance confirmation: QP designation documentation, complaint handling system, FSCA/recall capability
• Obtain 2 references from current foreign principal manufacturers — ask specifically about DAV registration timelines delivered vs committed
• Verify GDP-compliant warehouse — request facility inspection or recent audit documentation
• Review draft distribution and registration agreement: specify registration transfer process, who holds and provides the technical file, and timeline obligations for conversion from Import Permit to full registration

Common Mistakes to Avoid

• Appointing an importer with a high Import-Permit-to-Registration ratio — this signals poor registration conversion capability and creates long-term compliance risk as DAV tightens permit renewal requirements from 2025
• Failing to secure a Registration Transfer clause in the distribution agreement — without it, you are commercially vulnerable if the relationship deteriorates, as the Giấy lưu hành belongs to the importer
• Underestimating Vietnamese labelling requirements — all labelling and IFU must include Vietnamese-language text. English-only labelling is not accepted and will cause submission rejection
• Assuming DAV published timelines are realistic — plan for 50–100% additional time given historical backlogs. Use Import Permits strategically as a bridging mechanism, not a permanent solution
• Not conducting ongoing licence monitoring — DAV has increased enforcement activity since 2023, and importers with compliance issues can face sudden licence suspension that will disrupt your supply chain